Chronic Pain Clinical Trial
Official title:
Co-development and Assessment of the Feasibility and Potential Effects of an Online Self-management Program for Chronic Non-cancer Pain
NCT number | NCT05319652 |
Other study ID # | 2022-6312 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 6, 2022 |
Est. completion date | March 23, 2023 |
Verified date | July 2023 |
Source | CHU de Quebec-Universite Laval |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Based on a mixed-methods design, the objective of this trial is to assess the feasibility and acceptability of the "Agir pour moi" program, an 8-week online self-management program for chronic non-cancer pain (CNCP). The investigators will also explore its potential effects on self-efficacy, pain interference, pain severity, anxiety, depression, catastrophizing, and global impression of change in adults with CNCP awaiting services from a chronic pain multidisciplinary treatment center.
Status | Completed |
Enrollment | 63 |
Est. completion date | March 23, 2023 |
Est. primary completion date | March 23, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years; - live with CNCP for more than 3 months; - read and understand French easily; - have access to a computer and high-speed Internet; - be available to take part in the project for 6 to 8 months; - not having started a new treatment for pain within the last month; - agree to notify the team before starting a new treatment; - be able to give informed consent. Exclusion Criteria: - be supported by a multidisciplinary treatment center or be likely to be in the short term; - having participated in a CNCP self-management program within the last year; - be awaiting scheduled surgical treatment within six months. |
Country | Name | City | State |
---|---|---|---|
Canada | CHU de Québec | Québec | Quebec |
Lead Sponsor | Collaborator |
---|---|
CHU de Quebec-Universite Laval |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of the recruitment | Number of potentially eligible adults referred by the multidisciplinary treatment center over the recruitment period
Number of referred adults who respond to the invitation Number of referred adults who consent to participate in the study Number of interested adults excluded based on inclusion/exclusion criteria |
Baseline | |
Primary | Feasibility of data collection | Rate of response to the questionnaires
Rate of completed questionnaires (no missing data) |
Baseline | |
Primary | Feasibility of data collection | Rate of response to the questionnaires
Rate of completed questionnaires (no missing data) |
Post-intervention (8 weeks) | |
Primary | Feasibility of data collection | Rate of response to the questionnaires
Rate of completed questionnaires (no missing data) |
3 months post-intervention | |
Primary | Acceptability | The Acceptability E-scale includes 6 items regarding how easy and enjoyable the program was to use, how understandable were the lessons, how helpful was completing the program, whether the participant liked the program, whether the amount of time to complete the program was acceptable, and overall satisfaction with the program. Scores can range from 6 to 30. Higher scores reprensent a high level of acceptability. | Post-intervention (8 Weeks) | |
Primary | Acceptability | Qualitative data from semi-structured interviews | 4 months post-intervention | |
Primary | Adherence to the program | Completion rate of the program (completion is following = 75% of the lessons) | Post-intervention (8 weeks) | |
Secondary | Change in self-efficacy: French version of the Pain Self-Efficacy Questionnaire (PSEQ) | The PSEQ is a ten item questionnaire which assesses an individual's confidence in their ability to perform a variety of activities or tasks despite pain. Scores can range from 0 to 60. Higher scores represent lower confidence to function with pain. | Baseline; Post-intervention (8 weeks); 3 months post-intervention | |
Secondary | Change in pain severity and pain interference: French version of the Brief Pain Inventory (BPI) | The BPI includes a pain severity subscale and a pain interference subscale. The pain interference subscale measures the extent to which pain interferes with functions such as general activity, walking ability, normal work, mood, relationships with people, enjoyment of life and sleep. For each scale, the total score is the average of all items. Scores can range from 0 to 10 for each subscale. Higher scores indicate greater severity and more interference. | Baseline; Post-intervention (8 weeks); 3 months post-intervention | |
Secondary | Change in anxiety and depression: French version of the Hospital Anxiety and Depression Scale (HADS) | The HADS is a 14-item scale. Seven items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale. | Baseline; Post-intervention (8 weeks); 3 months post-intervention | |
Secondary | Change in pain catastrophizing: French version of the Pain Catastrophizing Scale (PCS) | The PCS is a 13-item questionnaire designed to assess catastrophic thinking in relation to pain. It yields a total score and three subscale scores assessing rumination, magnification and helplessness. Scores can range from 0 to 52. Higher scores represent higher pain catastrophizing. | Baseline; Post-intervention (8 weeks); 3 months post-intervention | |
Secondary | Patient Global Impression of Change Scale (PGIC) | The PGIC measures a patient's rating of overall improvement or lack thereof due to the intervention. It is a 7 point scale depicting a patient's rating of overall improvement. Patients rate their change as "very much improved," "much improved," "minimally improved," "no change," "minimally worse," "much worse," or "very much worse." | Post-intervention (8 weeks); 3 months post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|